ERCC1 and non-small cell lung carcinoma: In addition, our results showed that the ability of EGFR‐mutant and wild‐type NSCLC cell lines to form ERCC1 foci in response to cisplatin correlated with their survival after cisplatin treatment (Fig 2c).